Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Cullinan Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 149
- +4 vs. Q4 2024
- Shares held
- 64.7M
- +457.1K (+0.7%) vs. Q4 2024
- Total value
- $489.6M
- −$292.6M (−37.4%) vs. Q4 2024
- New holders
- 27
- 44 more added
- Sold out
- 23
- 50 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 80,100 | $606.4K | 0.02% | +80,100 | New |
| UBS Asset Management Americas Inc | 80,353 | $608.3K | 0.00% | −11,439−12.5% | Reduced |
| Citigroup Inc | 81,000 | $613.2K | 0.00% | +327+0.4% | Added |
| Acadian Asset Management LLC | 81,721 | $618.0K | 0.00% | +81,721 | New |
| Woodline Partners LP | 81,741 | $618.8K | 0.00% | −85,574−51.1% | Reduced |
| American Century Companies Inc | 112,670 | $852.9K | 0.00% | +11,949+11.9% | Added |
| BNP Paribas Arbitrage, SA | 129,721 | $982.0K | 0.00% | +14,721+12.8% | Added |
| Bank of New York Mellon Corp | 136,414 | $1.03M | 0.00% | −1,202−0.9% | Reduced |
| Wellington Management Group LLP | 161,057 | $1.22M | 0.00% | +28,081+21.1% | Added |
| Voss Capital, LLC | 175,000 | $1.32M | 0.10% | +52,639+43.0% | Added |
| Nuveen, LLC | 188,030 | $1.42M | 0.00% | +188,030 | New |
| Algert Global LLC | 221,430 | $1.68M | 0.04% | +178,138+411.5% | Added |
| Barclays PLC | 241,343 | $1.83M | 0.00% | −3,888−1.6% | Reduced |
| Affinity Asset Advisors, LLC | 263,817 | $2.00M | 0.31% | 00.0% | Unchanged |
| UBS Group AG | 278,819 | $2.11M | 0.00% | +43,106+18.3% | Added |
| Renaissance Technologies LLC | 363,008 | $2.75M | 0.00% | +172,500+90.5% | Added |
| Charles Schwab Investment Management Inc | 424,262 | $3.21M | 0.00% | −6,709−1.6% | Reduced |
| Morgan Stanley | 481,832 | $3.65M | 0.00% | −156,237−24.5% | Reduced |
| Northern Trust Corp | 483,889 | $3.66M | 0.00% | −17,019−3.4% | Reduced |
| Bank of America Corp | 524,385 | $3.97M | 0.00% | +369,115+237.7% | Added |
| Marshall Wace, LLP | 567,999 | $4.30M | 0.01% | −83,694−12.8% | Reduced |
| Deutsche Bank AG | 575,531 | $4.36M | 0.00% | −4,605−0.8% | Reduced |
| Twin Focus Capital Partners, LLC | 595,489 | $4.51M | 0.70% | 00.0% | Unchanged |
| Foresite Capital Management VI LLC | 634,558 | $4.80M | 2.63% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 644,633 | $4.88M | 0.28% | −97,481−13.1% | Reduced |
| Goldman Sachs Group Inc | 648,957 | $4.91M | 0.00% | −36,417−5.3% | Reduced |
| Millennium Management LLC | 783,177 | $5.93M | 0.01% | −50,785−6.1% | Reduced |
| Patient Square Capital LP | 878,897 | $6.65M | 2.75% | 00.0% | Unchanged |
| Braidwell LP | 980,773 | $7.42M | 0.26% | −195,400−16.6% | Reduced |
| Tang Capital Management LLC | 1,121,138 | $8.49M | 0.47% | +200,000+21.7% | Added |
| Nextech Invest, Ltd. | 1,141,145 | $8.64M | 2.01% | +1,141,145 | New |
| Siren, L.L.C. | 1,193,410 | $9.03M | 0.51% | −17,947−1.5% | Reduced |
| Geode Capital Management, LLC | 1,241,817 | $9.40M | 0.00% | +27,176+2.2% | Added |
| Dimensional Fund Advisors LP | 1,303,221 | $9.87M | 0.00% | −15,151−1.1% | Reduced |
| VR Adviser, LLC | 1,379,965 | $10.4M | 0.89% | 00.0% | Unchanged |
| RTW Investments, LP | 1,705,960 | $12.9M | 0.20% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 1,723,001 | $13.0M | 0.00% | −288,524−14.3% | Reduced |
| State Street Corp | 1,752,679 | $13.3M | 0.00% | −371,805−17.5% | Reduced |
| OrbiMed Advisors LLC | 1,923,855 | $14.6M | 0.35% | −18,700−1.0% | Reduced |
| Franklin Resources Inc | 2,219,761 | $16.8M | 0.00% | +20,052+0.9% | Added |
| Kynam Capital Management, LP | 2,338,629 | $17.7M | 1.51% | +1,085,891+86.7% | Added |
| Blue Owl Capital Holdings LP | 2,435,972 | $18.4M | 5.95% | +65,000+2.7% | Added |
| Citadel Advisors LLC | 2,747,145 | $20.8M | 0.02% | +64,241+2.4% | Added |
| Vanguard Group Inc | 3,039,731 | $23.0M | 0.00% | +103,504+3.5% | Added |
| Lynx1 Capital Management LP | 3,215,722 | $24.3M | 8.72% | +1,957,927+155.7% | Added |
| Deerfield Management Company, L.P. (Series C) | 3,860,839 | $29.2M | 0.58% | +481,440+14.2% | Added |
| BlackRock, Inc. | 4,220,862 | $32.0M | 0.00% | −150,163−3.4% | Reduced |
| BVF Inc | 5,750,683 | $43.5M | 1.77% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 7,648,268 | $57.9M | 9.95% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,030,438−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −907,895−100.0% | Sold out |
| Foresite Capital Management V, LLC | 0 | $0 | 0.00% | −657,905−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −504,264−100.0% | Sold out |
| Springhill Fund Asset Management (HK) Co Ltd | 0 | $0 | 0.00% | −276,400−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −205,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −130,647−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −94,344−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −74,843−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −66,135−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −43,987−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −30,747−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,101−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −18,657−100.0% | Sold out |
| Long Corridor Asset Management Ltd | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,609−100.0% | Sold out |
| Optimize Financial Inc | 0 | $0 | 0.00% | −11,755−100.0% | Sold out |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 0 | $0 | 0.00% | −11,153−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −5,986−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −5,828−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −1,317−100.0% | Sold out |
| BFSG, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Nextech Invest AG | – | – | – | – | Not filed |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |